Biogen Inc. buy Morgan Stanley
Start price
10.11.23
/
50%
€209.00
Target price
10.11.24
€349.02
Performance (%)
-22.34%
End price
11.11.24
€162.30
Summary
This prediction ended on 11.11.24 with a price of €162.30. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -22.34%. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -1.909% | -1.909% | 16.581% |
| iShares Core DAX® | -6,02 % | -4,60 % | 1,27 % |
| iShares Nasdaq 100 | 0,51 % | 0,16 % | 14,57 % |
| iShares Nikkei 225® | -7,16 % | -2,21 % | 28,11 % |
| iShares S&P 500 | -0,26 % | -0,84 % | 10,20 % |
Comments by Morgan_Stanley for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Morgan Stanley from $361.00 to $373.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten